Big Pharma companies are still betting big on AI, with major players pouring resources into agent platforms. The goal: unify fragmented data, streamline operations from clinical trials to sales, and enable more personalized healthcare provider interactions. Novartis has selected Salesforce’s Agentforce Life Sciences for a global rollout over the next five years. The deal follows…
Transforming pharmacovigilance with GenAI for faster, safer drug approval
As we approach the second quarter of the 21st century, speed is a driving force in the pharmaceutical environment. The industry currently faces a critical challenge in drug lifecycle management: how to accelerate drug safety monitoring while sticking to stringent safety and regulatory standards. Traditional methods of processing safety cases—essential for tracking adverse effects and…
4 waves of NLP techniques and how to stitch them together
While clinical trials and regulatory filings offer a semi-structured view of drug safety, a large amount of insights lie in sources ranging from patient support programs (PSPs) to social media posts. As Natural Language Processing (NLP) evolves, a growing number of tools are becoming available to unlock this potential. Deepanshu Saini, Director of Program Management…


